A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11)

Cancer Genetics and Cytogenetics

Volumn 148, Issue 2, 2004, Pages 137-140

  Anelli, Luisa ^a,b   Albano, Francesco ^a   Zagaria, Antonella ^a   Liso, Arcangelo ^a   Roberti, Maria Grazia ^b   Rocchi, Mariano ^a   Specchia, Giorgina ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CELL PROLIFERATION; CHROMOSOME 11; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CHROMOSOME VARIANT; CHRONIC MYELOID LEUKEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; HUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0347090580     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00246-2     Document Type: Article

References (13)

1. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated February 2003. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman .
2. Hagemeijer A., de Klein A., Godde-Salz E., Turc-Carel C., Smit E.M., van Agthoven A.J., Grosveld G.C. Translocation of c-abl1 to "masked" Ph in chronic myeloid leukemia. Cancer Genet Cytogenet. 18:1985;95-104.
3. Sinclair P.B., Nacheva E.P., Leversha M., Telford N., Chang J., Reid A., Bench A., Champion K., Huntly B., Green A.R. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood. 95:2000;738-743.
4. Albano F., Specchia G., Anelli L., Zagaria A., Storlazzi C.T., Buquicchio C., Roberti M.G., Liso V., Rocchi M. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases. Genes Chromosomes Cancer. 36:2003;353-360.
5. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
6. Storlazzi C.T., Specchia G., Anelli L., Albano F., Pastore D., Zagaria A., Rocchi M., Liso V. Breakpoint characterization of der(9) deletions in CML patients. Genes Chromosomes Cancer. 35:2002;271-276.
7. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
8. Sevenet N., Lellouch-Tubiana A., Schofield D., Hoang-Xuan K., Gessler M., Birnbaum D., Jeanpierre C., Jouvet A., Delattre O. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet. 8:1999;2359-2368.
9. Chen H., Sandler D.P., Taylor J.A., Shore D.L., Liu E., Bloomfield C.D., Bell D.A. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 347:1996;295-297.
10. Gabig T.G., Mantel P.L., Rosli R., Crean C.D. Requiem: a novel zinc finger gene essential for apoptosis in myeloid cells. J Biol Chem. 269:1994;29515-29519.
11. Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., Nakatani Y. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell. 102:2000;463-473.
12. Sotiropoulou G., Anisowicz A., Sager R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem. 272:1997;903-910.
13. Quon K.C., Berns A. Haplo-insufficiency? Let me count the ways. Gene Dev. 15:2001;2917-2921.